Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Domenico Rubello

Showing results (321-330 of 471) with videos related to

Pageof 48
Sort By:
In Vivo (Athens, Greece)|April 17, 2009
11C-methionine vs. 18F-FDG PET in soft tissue sarcoma patients treated with neoadjuvant therapy: preliminary resultsGiulia Ghigi, Renato Micera, Anna Margherita Maffione, et al.
Leukemia & Lymphoma|July 15, 2006
Discordant response to chemotherapy: an unusual pattern of fluoro-deoxy-D-glucose uptake in heavily pre-treated lymphoma patientsLapo Alinari, Valentina Ambrosini, Paolo Castellucci, et al.
Annals of Nuclear Medicine|June 15, 2010
Role of 11C-choline PET/CT in the restaging of prostate cancer patients showing a single lesion on bone scintigraphyChiara Fuccio, Paolo Castellucci, Riccardo Schiavina, et al.
Clinical Nuclear Medicine|November 8, 2016
Sentinel Lymph Node Biopsy in Cutaneous Melanoma: Standard and New Technical Procedures and Clinical Advances. A Systematic Review of the LiteratureElisa Tardelli, Sara Mazzarri, Domenico Rubello, et al.
Clinical Nuclear Medicine|February 25, 2014
Sentinel lymph node mapping in melanoma: the issue of false-negative findingsGianpiero Manca, Domenico Rubello, Antonella Romanini, et al.
Nuclear Medicine Communications|November 20, 2010
Increased serum thyroglobulin levels and negative imaging in thyroid cancer patients: are there sources of benign secretion? A speculative short reviewPaolo Zanotti-Fregonara, Isabelle Keller, Marie Calzada-Nocaudie, et al.
Nuclear Medicine Communications|April 27, 2007
Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumoursValentina Ambrosini, Paola Tomassetti, Domenico Rubello, et al.
Clinical Nuclear Medicine|September 24, 2014
11C-choline PET/CT and bladder cancer: lymph node metastasis assessment with pathological specimens as reference standardFrancesco Ceci, Lorenzo Bianchi, Tiziano Graziani, et al.
American Journal of Clinical Oncology|May 11, 2016
Thyroid Paraganglioma: Our Experience and Systematic Review of the Literature on a Rare TumorMaria Rosa Pelizzo, Christian Conti, Gianmaria Pennelli, et al.
European Journal of Radiology|May 25, 2012
Role of 11C-choline PET/CT in the re-staging of prostate cancer patients with biochemical relapse and negative results at bone scintigraphyChiara Fuccio, Paolo Castellucci, Riccardo Schiavina, et al.
Pageof 48

Showing results (321-330 of 471) with videos related to

Sort By:
Pageof 48
In Vivo (Athens, Greece)|April 17, 2009
11C-methionine vs. 18F-FDG PET in soft tissue sarcoma patients treated with neoadjuvant therapy: preliminary resultsGiulia Ghigi, Renato Micera, Anna Margherita Maffione, et al.
Leukemia & Lymphoma|July 15, 2006
Discordant response to chemotherapy: an unusual pattern of fluoro-deoxy-D-glucose uptake in heavily pre-treated lymphoma patientsLapo Alinari, Valentina Ambrosini, Paolo Castellucci, et al.
Annals of Nuclear Medicine|June 15, 2010
Role of 11C-choline PET/CT in the restaging of prostate cancer patients showing a single lesion on bone scintigraphyChiara Fuccio, Paolo Castellucci, Riccardo Schiavina, et al.
Clinical Nuclear Medicine|November 8, 2016
Sentinel Lymph Node Biopsy in Cutaneous Melanoma: Standard and New Technical Procedures and Clinical Advances. A Systematic Review of the LiteratureElisa Tardelli, Sara Mazzarri, Domenico Rubello, et al.
Clinical Nuclear Medicine|February 25, 2014
Sentinel lymph node mapping in melanoma: the issue of false-negative findingsGianpiero Manca, Domenico Rubello, Antonella Romanini, et al.
Nuclear Medicine Communications|November 20, 2010
Increased serum thyroglobulin levels and negative imaging in thyroid cancer patients: are there sources of benign secretion? A speculative short reviewPaolo Zanotti-Fregonara, Isabelle Keller, Marie Calzada-Nocaudie, et al.
Nuclear Medicine Communications|April 27, 2007
Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumoursValentina Ambrosini, Paola Tomassetti, Domenico Rubello, et al.
Clinical Nuclear Medicine|September 24, 2014
11C-choline PET/CT and bladder cancer: lymph node metastasis assessment with pathological specimens as reference standardFrancesco Ceci, Lorenzo Bianchi, Tiziano Graziani, et al.
American Journal of Clinical Oncology|May 11, 2016
Thyroid Paraganglioma: Our Experience and Systematic Review of the Literature on a Rare TumorMaria Rosa Pelizzo, Christian Conti, Gianmaria Pennelli, et al.
European Journal of Radiology|May 25, 2012
Role of 11C-choline PET/CT in the re-staging of prostate cancer patients with biochemical relapse and negative results at bone scintigraphyChiara Fuccio, Paolo Castellucci, Riccardo Schiavina, et al.
Pageof 48